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Abstract
Malectin is a conserved, endoplasmic reticulum (ER)-resident lectin that recognizes high mannose oligosaccharides displaying
terminal glucose residues. Here we show that Malectin is an ER stress-induced protein that selectively associates with
glycopolypeptides without affecting their entry and their retention in the Calnexin chaperone system. Analysis of the obligate
Calnexin client influenza virus hemagglutinin (HA) revealed that Calnexin and Malectin associated with different timing to
different HA conformers and that Malectin associated with misfolded HA. Analysis of the facultative Calnexin clients NHK and a1-
antitrypsin (a1AT) revealed that induction of Malectin expression to simulate conditions of ER stress resulted in persistent
associationbetweentheERlectinandthemodelcargoglycoproteins,interferedwithprocessingofcargo-linkedoligosaccharides
and reduced cargo secretion. We propose that Malectin intervention is activated upon ER stress to inhibit secretion of defective
gene products that might be generated under conditions of aberrant functioning of the ER quality control machinery.
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Introduction
In Eukarya, pre-assembled glucose3-mannose9-N-acetylglucosa-
mine2- oligosaccharides (Fig. 1A) are transferred from a lipid
donor in the ER membrane onto Asn-X-Ser/Thr sequons of
nascent polypeptide chains emerging in the ER lumen. The
processing of protein-bound oligosaccharides determines the fate of
the associated polypeptide chains. The intervention of several ER-
resident sugar processing and sugar binding proteins in protein
folding and quality control has been reported [1,2]. Briefly, the
translocon-associated a-glucosidase I removes the outermost
glucose residue as soon as the oligosaccharide is covalently attached
to the polypeptide chain emerging in the ER lumen. Immediately
after, the soluble a-glucosidase II removes the second glucose. This
generates a mono-glucosylated oligosaccharide that recruits the
lectin chaperones Calnexin and Calreticulin as well as the
oxidoreductase ERp57 [3,4]. ERp57 catalyses formation of inter-
and intramolecular disulfide bonds, a rate-determining step in
polypeptide folding. The oxidative polypeptide folding in the
Calnexin chaperone system starts co-translationally, as soon as the
first native disulfide pair emerges into the ER lumen, and is
concluded post-translationally [5]. The co-translational association
of nascent glycopolypeptides with Calnexin and Calreticulin [6,7,8]
shows that generation of the mono-glucosylated intermediate of the
oligosaccharide processing might occur in a matter of few seconds.
Native polypeptides released from the Calnexin chaperone system
are de-glucosylated by the a-glucosidase II, exit the ER and are
transported at their intra- or extracellular site of activity. However,
if the folding program has not been completed, one terminal
glucose residue is added-back by the folding sensor UDP-
glucose:glycoprotein glucosyltransferase (UGT1) to prolong folding
attempts in the Calnexin folding environment [9]. The removal of
up to 4 terminal mannose residues by the ER mannosidase I and by
EDEM proteins eventually interrupts unproductive retention in the
folding environment and directs terminally misfolded polypeptides
to dislocons at the ER membrane. Dislocons contain adaptor
proteins and membrane-embedded E3 ubiquitin ligases that
regulate substrate retro-translocation across the ER membrane
for proteasomal degradation [10,11,12].
The recent discovery of Malectin, an ER-resident protein that
binds oligosaccharides displaying terminal glucose residues with a
strong preference for di-glucosylated ones in vitro [13,14,15], led to
many speculations on a possible involvement of this lectin in the
Calnexin chaperone system and in glycoprotein quality control in
the mammalian ER [1,2].
Here we show that Malectin is an ER stress-induced type I
membrane protein that associates with newly synthesized glyco-
proteins in living cells. Analysis of the influenza virus HA revealed
that Calnexin and Malectin had distinct kinetics of association
with newly synthesized polypeptides and that Malectin preferen-
tially associated with misfolded HA conformers. Changes in the
intralumenal levels of Malectin did not affect the function of the
Calnexin chaperone system or the maturation of HA, an obligate
Calnexin substrate. It is therefore unlikely that Malectin
participates in the Calnexin chaperone system. On the other
hand, enhancement of Malectin expression to simulate ER-stress
conditions resulted in prolonged Malectin association with two
a1AT variants used here as model cargo glycoproteins. Even
though we did not assess the oligosaccharide specificity of Malectin
in the living cell, our data showed that Malectin association with
glycoproteins might affect processing of N-linked oligosaccharides
and might substantially reduce secretion of select cargo proteins.
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Malectin topology and properties
Malectin is an ER-resident protein as shown by its co-
localization with the conventional ER marker Calnexin in indirect
immunofluorescence (Fig. 1B and [14]). We first determined the
membrane topology of Malectin because only the luminal
orientation of the protein’s carbohydrate binding-site would be
consistent with a role of this protein in ER quality control. To this
end, mammalian cultured cells were transfected with a plasmid for
Figure 1. Subcellular localization, topology and ER stress induction of Malectin. A The asparagine-linked core oligosaccharide is composed
of two N-acetylglucosamine (squares), nine mannose (circles) and three glucose residues (triangles). B Ectopically expressed Malectin-HA was visualized
with an anti-HA antibody (left panel), Calnexin with a polyclonal antibody recognizing the endogenous protein (right panel). C Luminal vs membrane
localization ofERchaperones was assessedafter carbonate extraction ofmicrosomes. D Intactmicrosomeswereincubated withorwithout (Mock) trypsin
toremovecytosolic portionsofthelabeledpolypeptidechains.CalnexinDClacks the 90cytosolic residues.Molecularweightmarkers(200, 116,97,66,45,
30 kDa) are shown on the right. E Human Malectin comprises 292 residues. The signal sequence and the transmembrane anchor are in bold, the putative
N-glycosylation site is underlined. F Thapsigargin (Tg) triggers ER stress (uXBP1 and sXBP1 are unspliced and spliced XBP1 transcripts, respectively). Fold-
induction of BiP, Grp94, EDEM1 and Malectin transcripts as determined by real time PCR (in triplicate). Actin served as negative control.
doi:10.1371/journal.pone.0016304.g001
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transfection, cells were pulsed for 15 minutes with
35S-methionine
and -cysteine to be then broken with 10–13 passages through a
needle. After removal of nuclei and cytosol, the luminal content of
endomembranes was separated from the membrane fraction upon
carbonate extraction as described in [16]. Calreticulin, a marker of
the ER lumen, was mainly immunoisolated from the luminal
fraction (Fig. 1C, lane 1 vs 4). Calnexin, a marker of the ER
membrane (lane 5 vs 2), and Malectin (lane 6 vs 3) were mainly
immunoisolated from the membrane fraction.
To assess the orientation of Malectin in the ER, microsomes
were mock-treated (Fig. 1D, lanes 1–3) or incubated for 1 hour at
37uC with trypsin to remove the cytosolic portion of microsomal
proteins. Trypsin treatment did not modify the electrophoretic
mobility of Malectin (Fig. 1D, lane 1 vs 4) and of Calreticulin (lane
2 vs 5). For Calreticulin, this was expected because Calreticulin is a
luminal protein and remains therefore inaccessible to trypsin. For
Malectin, this showed that the bulk of the polypeptide chain is
located in the ER lumen. As a positive control, trypsin-treatment
changed the electrophoretic mobility of Calnexin by removing the
90 cytosolic C-terminal residues of this type I protein (Fig. 1D,
lane 6, Calnexin DC).
Consistent with these experimental data, the use of SignalP 3.0
[17] and PSORT II [18] algorithms to predict signal sequence
versus transmembrane sequences in Malectin revealed a signal
peptide from residues 1 to 27, a transmembrane region between
residues 271–290 and a cytosolic tail comprising only two residues
(Fig. 1E and [14]). Malectin contains a consensus sequence for N-
glycosylation, which is not used, most likely because the acceptor
asparagine residue (underlined in Fig. 1E) is adjacent to the
transmembrane anchor.
Malectin expression is induced upon ER stress
To determine whether the expression level of Malectin was
enhanced under ER stress conditions, cultured cells were mock-
treated or exposed to 300 ng/ml thapsigargin (Tg) for up to 8 hr
before determining the level of BiP, EDEM1, Grp94 and Malectin
transcripts by Real Time PCR. The splicing of Xbp1 transcripts
confirmed activation of the unfolded protein response (Fig. 1F).
The Real Time analysis revealed a 7-fold induction of BiP, a 3.5-
fold induction of EDEM1 and a 2-fold induction of Grp94 and
Malectin transcripts (Fig. 1F). Thus, Malectin expression is
enhanced in response to accumulation of misfolded polypeptides
in the ER lumen.
Changes in Malectin levels do not affect biogenesis of
influenza virus HA
Influenza virus HA is a canonical model substrate used in the
past 20 years to characterize the mechanisms regulating
chaperone-assisted glycoprotein maturation in the ER of mam-
malian cells [4,8,19,20,21,22]. HA acquires 6 native intramolec-
ular disulfide bonds (Fig. 2A) in association with Calnexin,
Calreticulin and ERp57. It is defined as an obligate client of the
Calnexin chaperone system because any perturbation of the
activity of a-glucosidases, Calnexin, Calreticulin, ERp57 or UGT1
results in substantial folding defects [19,23,24,25]. HA is therefore
an appropriate substrate to determine whether the glucose-binding
lectin Malectin interferes with the function of Calnexin, which also
associates with newly synthesized polypeptides displaying glucosy-
lated oligosaccharides [4].
Four hours after infection with influenza virus, HEK293 cells
were metabolically labeled and the viral polypeptides (the
glycoprotein HA and the non-glycoprotein NP in Fig. 2) were
immunoisolated from cell lysates after 2, 20 and 60 min chase in
the absence of radioactivity.
Separation of the proteins in nonreducing gels, revealed three
HA folding intermediates with different oxidation states after
2 min chase (Fig. 2B, lane 1; IT1 contains only small loop
disulfides, IT2 also contains the Cys52-Cys277 disulfide, NT is
fully oxidized [21]). The ratio between incompletely (IT1+IT2)
and fully oxidized HA (NT) was 3:5 indicating that oxidative HA
folding was still in progress. After 20 min chase, the oxidative
phase of HA folding had virtually been completed and most of the
labeled HA migrated as a single polypeptide band in nonreducing
gels (NT, Fig. 2B, lane 2). After 60 min chase (lane 3), the
amount of radio-labeled HA immunoisolated from HEK293 cells
decreased because the protein enters in membranes poorly soluble
in CHAPS, the zwitterionic detergent used in these experi-
ments to preserve chaperones:HA complexes (see below), and
because viral particles containing labeled HA are released from
infected cells. Efficient maturation of HA was confirmed by the
progressive attainment of EndoH-resistant oligosaccharides that
occurs when native HA traverses the Golgi compartment
(Fig. 2C, lanes 1–6).
Repetition of the experiments in HEK293 cells stably expressing
elevated levels of Malectin (HEK293Mal) failed to reveal significant
differences. After 2 min chase, infected HEK293Mal cells con-
tained the same ratio of incompletely (IT1+IT2) vs fully oxidized
HA (NT, Fig. 2B, lane 4) as HEK293 cells. After 20 min chase,
HA oxidation was virtually complete (lane 5) and the attainment of
EndoH-resistant oligosaccharides also progressed as in cells
expressing normal levels of Malectin (Fig. 2C, lanes 7–12).
Likewise, the reduction of the intralumenal level of Malectin upon
specific RNA interference did not affect oxidative HA maturation
(Fig. S1). The finding that variations in the intralumenal level of
Malectin do not affect HA folding implies that Malectin is not an
essential component of the Calnexin chaperone system whose
unperturbed function is required for productive HA maturation
[19,23,24,25].
Malectin does not affect oxidative folding of Calnexin-
associated HA
To confirm that Malectin overexpression does not affect the
function of the Calnexin chaperone system, Calnexin and the
associated HA conformers were immunoisolated from HEK293
and HEK293Mal cell lysates. Analysis in nonreducing gels
showed that after 2 min chase, all three HA folding intermediates
were associated with Calnexin in HEK293 cells (Fig. 2D,
lane 1). The ratio (IT1+IT2):NT was 5:3, thus confirming the
preferential association of incompletely oxidized HA folding
intermediates with the lectin chaperone [4,5,19,25]. After 20 min
chase, oxidative HA folding had virtually been completed
(Fig. 2B, lane 2). Consistently, Calnexin had released most of
the labeled HA (Fig. 2D, lane 2). HA release from Calnexin is
better appreciated in reducing gels, in which IT1, IT2 and NT
migrate as a single polypeptide band (HA in lanes 7–9). In
HEK293Mal cells, the same amount of radio-labeled, newly
synthesized HA did associate with Calnexin (Fig. 2D, compare
lane 4 with 1 in the nonreducing gel and lane 10 with 7 in the
reducing gel). This showed that high levels of luminal Malectin
do not interfere with HA association with Calnexin. Malectin
overexpression did also not affect the ratio of (IT1+IT2):NT
transiently associated with Calnexin (compare lane 4 with 1), or
the kinetics of HA release from Calnexin during the chase
(compare lanes 10–12 with 7–9, and quantitation in Fig. 2H,
upper panel).
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PLoS ONE | www.plosone.org 3 January 2011 | Volume 6 | Issue 1 | e16304Figure 2. Consequences of Malectin overexpression on HA maturation. A Schematics showing the cysteine residues covalently linked in the
native HA. B Influenza virus HA was immunoisolated from detergent lysates of influenza virus-infected cells with normal (lanes 1–3) or elevated levels
of Malectin (stably transfected HEK293Mal cells, lanes 4–6). The folding intermediates IT1, IT2 and NT are shown. The viral, non-glycosylated nuclear
protein (NP) is also recognized by the antibody used. Molecular weight markers (200, 116, 97, 66 kDa) are shown on the right. C Assessment of
EndoH-sensitivity of oligosaccharides displayed on HA in HEK293 (lanes 1–6) and in HEK293Mal cells (lanes 7–12). Res, EndoH-resistant HA; Sens,
EndoH-sensitive HA. The % of EndoH-resistant HA (Res in the upper panel) has been quantified. This gel is representative of a series of experiments in
which HA maturation was monitored at different chase times. D Release of HA from Calnexin in HEK293 (lanes 1–3 (non reducing gel); lanes 7–9
Malectin and Quality Control
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affect substrate association with Calnexin
Unperturbed Calnexin function upon Malectin overexpression
was not a peculiarity of cells infected with influenza virus. In fact,
the amount of labeled endogenous polypeptides associating with
Calnexin was essentially the same in HEK and in HEK293Mal
cells (compare lane 1 with 6 in Fig. 2E). The kinetic of release
from Calnexin of endogenous (Fig. 2E, lanes 1–5 vs 6–10) and of
ectopically expressed substrates (NHK (Fig. 2F) and a1AT
(Fig. 2G)) did also not vary upon elevation of the intralumenal
Malectin levels. Likewise, the reduction of the intralumenal level of
Malectin obtained upon RNA interference did not affect
association and kinetic of release from Calnexin of model
glycoproteins (Fig. S1). Thus, even though it binds glucosylated
oligosaccharides [13,14,15], Malectin does not compete with
Calnexin for association with newly synthesized polypeptides.
Malectin and Calnexin association with HA conformers
Next, we determined whether Malectin associates with influenza
virus HA. Analysis of the immunoprecipitates revealed a transient
association of Malectin with HA with a peak of binding after
20 min chase (Fig. 2H, lanes 4–6 and quantitation, lower panel),
when Calnexin had already released most of the newly synthesized
glycoprotein (Figs. 2D and 2H, quantitation, upper panel).
Analysis of the nonreducing gels showed that, unlike Calnexin
(Fig. 2D, lanes 1 and 4), Malectin preferentially associated with
the fully oxidized NT and less abundantly with the partially
oxidized HA conformers after 2 min chase (Fig. 2H, lane 4).
Association of extensively oxidized HA conformers persisted
during the chase and occurred in the ER because Malectin is
localized in the ER (Fig. 1) and because it associated with the
fraction of cellular HA (Fig. 2I, lanes 1–2) displaying EndoH-
sensitive oligosaccharides (lanes 3–4). The delayed kinetics of
binding (peak at 2 min for Calnexin and at 20 min for Malectin,
Fig. 2H) and the association of Malectin with more extensively
oxidized HA conformers revealed that Malectin and Calnexin do
associate with distinct HA populations.
HA misfolding enhances Malectin binding
The delayed association of Malectin with extensively oxidized
HA conformers retained in the ER (Figs. 2H-2I) led us to
hypothesize that Malectin might associate with a fraction of HA
characterized by slow attainment of the native structure or with
non-native HA. To check whether HA association with Malectin is
enhanced under conditions that inhibit HA maturation, influenza
virus infected cells were exposed to castanospermine (Cst). Cst
inhibits generation of mono-glucosylated oligosaccharides and
drastically reduces substrate association with Calnexin (Fig. 2K,
lane 2 vs 5 and [4,20]). Under these conditions, HA maturation is
substantially impaired as shown by the aberrant formation of HA-
containing disulfide-bonded complexes, which are retained in the
ER lumen upon association with the luminal chaperone BiP
[4,19,20,25,26]. Our data confirmed that cell exposure to Cst
results in progressive accumulation of HA-containing disulfide-
bonded aggregates (DBA), which are already visible after 2 min
chase in the presence of Cst (DBA in Fig. 2K, lane 4 vs 1) and
become more abundant after 20 min chase (lane 10 vs 7). Analysis
of the immunocomplexes containing Malectin and HA revealed
stronger association in cells exposed to Cst (lane 6 vs 3 after 2 min
chase and lane 12 vs 9 after 20 min chase). More importantly, the
co-precipitation of the high molecular weight HA-containing DBA
(lanes 6 and 12 in Fig. 2K) revealed that Malectin contributes
with BiP [25,26] as a crucial ER retention factor for misfolded
HA.
Malectin overexpression and cargo retention in the ER
lumen
HA is highly efficient folder and Malectin overexpression has no
substantial consequence on its maturation. However, the finding
that Malectin could be involved in ER-retention of folding-
defective/misfolded HA chains led us to assess whether Malectin
overexpression affects secretion of glyco-polypeptides character-
ized by slower, less efficient and less Calnexin-dependent
maturation. We therefore selected two a1AT variants as model
cargo proteins to be expressed in cells with variable Malectin
content. The Null Hong Kong variant of a1AT (NHK [27]) is
mostly degraded from the ER when ectopically expressed in sub-
confluent mammalian cultured cells [28] but, independent of its
expression level, about 20% of the synthesized protein is secreted
in the extracellular media [29]. Secretion of a1AT is more efficient
and reaches about 60% of the polypeptide chains entering the ER.
HEK293 cells were transiently transfected with a plasmid for
expression of NHK (Fig. 3A, lanes 1–3) or co-transfected for
expression of NHK and human Malectin (lanes 4–6). Seventeen
hours later, cells were metabolically labeled, chased for 10, 60 or
120 min and ectopically expressed NHK was immunoisolated
from cell lysates and separated in SDS-PAGE. Like HA and a1AT
(Figs. 2 and Fig. 3E, respectively), analysis of the labeled NHK
after a 10 min chase revealed the same electrophoretic mobility in
cells expressing normal (Fig. 3A, lane 1) and elevated levels of
Malectin (lane 4), consistent with unperturbed N-glycosylation of
nascent polypeptides. In the experiment shown in the figure, after
120 min chase, mock-transfected cells contained 36% of the initial
amount of labeled NHK (Fig. 3A, lane 3 vs 1). The amount of
residual intracellular NHK at the end of the chase was increased to
(reducing gel)) and in HEK293Mal cells (lanes 4–6 (non reducing); lanes 10–12 (reducing)). Calnexin and associated substrates have been
immunoisolated from the lysate of 200’000 cells. Lane aHA shows the ratio of IT1, IT2, NT in infected cells after 2 min chase and the mobility of NP,
which does not co-immunoprecipitate with Cnx (specificity control). Viral proteins in the lane aHA have been immunoisolated from the lysate of
20’000 cells. Molecular weight markers (116, 97, 66 kDa) are shown on the right. E Same as D for endogenous Calnexin substrates. Select
polypeptides are shown with A–I. F Same as D for ectopically expressed NHK. G Same as D for ectopically expressed a1AT. H Same as D for Malectin-
associated HA. The specificity of the anti-Malectin immunoprecipitation is confirmed by the low cross reactivity in infected cells that did not contain
ectopically expressed Malectin (lanes 1–3) and by the lack of co-precipitation of the non-glycosylated NP (lane 1) with Malectin (lanes 4–6).
Quantitations of HA release from Calnexin (upper panel, reducing gel, Fig. 2D)) and from Malectin (lower panel, gel in Fig. 2H) are shown. Ectopically
expressed Malectin-HA and the associated influenza virus HA have been immunoisolated from detergent extracts with an antibody to the HA-tag
sequence (YPYDVPDYA). This sequence is not present in the X-31 influenza virus HA (as confirmed by the lack of influenza virus protein in the
immunoisolates of cells not expressing Malectin-HA, lanes 1–3). I Same as C for the labelled HA immunoisolated from cells after 20 min chase (lanes
1–2) and for Malectin-associated HA (lanes 3–4) after 20 min chase. K HA immunoisolated after 2 min chase from cells in the absence (Mock, lane 1)
or in the presence of 1 mM Castanospermine (Cst, lane 4). The same for Calnexin-associated HA (Mock, lane 2; Cst, lane 5). The same for Malectin-
associated HA (Mock, lane 3; Cst, lane 6). The analysis was also performed for cells solubilised after 20 min chase (lanes 7–12). Since Cst inhibits
removal of glucose residues from HA-bound oligosaccharides, HA has slower electrophoretic mobility in lanes 4–6 and 10–12. The experiments
shown in panels I–K have been performed in HEK293Mal cells.
doi:10.1371/journal.pone.0016304.g002
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lane 6 vs 4). In these cells, Malectin did co-precipitate, throughout
the chase, with the labeled NHK retained intracellularly showing a
long-lasting association between the two proteins (-Mal in Fig. 3A,
lanes 4–6).
Malectin overexpression interferes with NHK secretion
NHK secretion was monitored by immunoisolation of the
labeled protein from the extracellular media harvested at the end
of each chase time. After a 10 min chase, which is insufficient for a
secretory protein to exit the cellular secretory line, the media of
Figure 3. Malectin overexpression interferes with oligosaccharide processing and cargo protein secretion. A Intracellular, labelled NHK
in HEK293 cells (lanes 1–3) and in HEK293 cells co-transfected with a plasmid for expression of Malectin-HA (lanes 4–6). Malectin co-precipitates with
NHK throughout the chase (lanes 4–6). Molecular weight markers (116, 97, 66, 45, 30 kDa) are shown on the right. Quantitations in panels A, B, E, G
are for at least two independent experiments (error bars represent SD). Data have also been reproduced in other cell lines (CHO cells in panel D, HeLa
cells transiently transfected for Malectin overexpression and HEK293Mal, not shown). B Same as A for secreted NHK. C Assessment of EndoH-
sensitivity of oligosaccharides displayed on NHK secreted from HEK293 cells (lanes 1–2) or from HEK293 cells co-transfected for expression of
Malectin-HA (lanes 3–4). The arrow shows the fraction of labelled NHK displaying EndoH-sensitive oligosaccharides in lane 4. D Same as C for NHK
secreted from CHO cells. E–G Same as A–C for a1AT. Molecular weight markers (116, 97, 66, 45 kDa) are shown on the right.
doi:10.1371/journal.pone.0016304.g003
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expressing cells (lane 4) did not contain labeled NHK. However,
with progression of the chase, the amount of NHK secreted from
wild type cells increased to reach the 24% of the synthesized
protein (Fig. 3B, lane 3). Consistent with the delay in
disappearance of radiolabeled NHK from the intracellular milieu
(Fig. 3A, lanes 4–6), overexpression of Malectin resulted in a
drastic decrease of NHK secretion to less than 10% of the
synthesized protein (Fig. 3B, lane 6).
Malectin overexpression results in secretion of NHK
displaying partly EndoH-sensitive N-glycans
Comparison of the electrophoretic mobility of NHK secreted
from wild type cells (Fig. 3B, lanes 2–3) or from cells expressing
high levels of Malectin (lanes 5–6), revealed a slightly faster
mobility of the latter polypeptide, a possible symptom of aberrant
processing of the NHK-bound oligosaccharides. Normally, N-
linked glycans displayed on secreted proteins are extensively
modified in the Golgi compartment to become resistant to EndoH
cleavage [30]. This was in fact observed for the NHK protein
secreted from wild type cells that remained fully glycosylated and
conserved the same gel mobility upon mock- and upon EndoH-
treatment (Fig. 3C, lanes 1 and 2, respectively). Instead, the NHK
secreted from cells expressing high levels of Malectin was partially
de-glycosylated upon EndoH-treatment, as shown by the gener-
ation of labeled polypeptide bands with faster electrophoretic
mobility upon exposure of the polypeptide to the endoglycanase
(Fig. 3C, arrow in lane 4). Thus, Malectin overexpression reduced
NHK secretion and resulted in secretion of NHK displaying
aberrant, partly EndoH-sensitive N-glycans.
Malectin overexpression interferes with efficient protein
de-glucosylation in the ER
Interestingly, inefficient attainment of EndoH-resistant oligo-
saccharides occurs when glycoproteins are released from the ER
before complete oligosaccharide de-glucosylation. Under these
circumstances, a salvage pathway must be activated in which
terminal glucoses must be removed by a Golgi-resident endo-a-D-
mannosidase before complex glycosylation can proceed [31,32].
We reasoned that Malectin binding to glucosylated oligosaccha-
rides [13,14,15] could interfere with the activity of ER a-
glucosidases thus resulting in unconventional release from the
ER of glucosylated polypeptides. To assess this, we repeated the
same experiments described above in Chinese hamster ovary
(CHO). CHO cells lack the Golgi-resident endo-a-D-mannosi-
dase. In these cells, release of glucosylated oligosaccharides from
the ER would be revealed by secretion of proteins displaying
EndoH sensitive glycans [33]. Like in HEK293 cells (Fig. 3C), the
NHK normally secreted from CHO cells displayed EndoH-
resistant oligosaccharides (Fig. 3D, lanes 1–2). However, when
Malectin was overexpressed, the vast majority of secreted NHK
displayed EndoH-sensitive oligosaccharides (compare lane 4 in
Fig. 3D with lane 4 in Fig. 3C). We therefore concluded that
Malectin associates with glucosylated oligosaccharides in the ER
lumen thereby interfering with their efficient de-glucosylation.
Malectin inhibits secretion of a1AT
The experiments with a1AT essentially confirmed the data
shown above. Malectin did co-precipitate with a1AT throughout
the chase thereby increasing the fraction of newly synthesized
a1AT retained intracellularly (from 14 to 47% in the experiment
shown in Fig. 3E, lanes 1–3 vs 4–6). Enhanced intracellular
retention corresponded to a substantial reduction of the secretion
of the labeled protein (from 65 to 18% in Fig. 3F, lanes 1–3 vs 4–
6). Moreover, the a1AT secreted from cells containing high levels
of Malectin was separated in two distinct polypeptide bands
(Fig. 3F–3G) displaying aberrant, partially EndoH-sensitive
oligosaccharides (arrow in Fig. 3G, lane 4). This confirmed that
Malectin overexpression interferes with normal processing of
oligosaccharides displayed on secretory cargo proteins and reduces
cargo protein secretion.
Discussion
Malectin, a novel ER lectin
Malectin is a novel sugar binding, ER-resident protein highly
conserved in Metazoa. It shares structural similarity with
carbohydrate binding modules (CBM) of prokaryotic glycosyl
hydrolases. In carbohydrate microarray analyses, Malectin binds
maltose, nigerose and related di-glucosides [13,14,15]. Amongst
lipid-linked high mannose oligosaccharides, Malectin shows a
strong preference for glucose2-mannose7-N-acetylglucosamine1-.
The much lower association of Malectin with glucose3-mannose7-
N-acetylglucosamine1- and glucose1-mannose9-N-acetyl glucos-
amine2- species might be ascribed to the presence of trace
contaminants in the glycans isolated from drug-treated cells [14].
In any case, glucosylated glycan structures are present in the ER
lumen of living cells as lipid-linked precursors in the ER
membrane and, after the intervention of the oligosaccharyl
transferase, as protein-bound tags that determine the fate of the
associated polypeptide [34,35]. For these reasons, the discovery of
Malectin led to many speculations on a possible involvement of
this lectin in the Calnexin chaperone system and in glycoprotein
quality control in the mammalian ER [1,2].
Malectin associates with newly synthesized glycoproteins
in the ER
The topology of Malectin reported in this study, with the
ectodomain containing the putative lectin site in the ER lumen, is
consistent with a role of Malectin in glycoprotein quality control.
Our data show that N-glycosylation of newly synthesized
polypeptides progresses normally upon Malectin overexpression.
We therefore consider unlikely that Malectin binds partially or
fully glucosylated lipid-linked oligosaccharides at the ER
membrane, as this would interfere with oligosaccharide synthesis
and/or with oligosaccharide transfer onto nascent polypeptide
chains. Rather, our data indicate that Malectin associates
with glycoproteins in the ER lumen. In fact, we report the
immunoisolation from cell lysates and the characterization of
complexes containing Malectin and newly synthesized HA
retained in the ER as well as the detection of complexes
containing Malectin and two soluble cargo glycoproteins, NHK
and a1AT.
Malectin does not compete with Calnexin for substrate
binding
Malectin does associate with glucosylated oligosaccharides in
vitro [13,14,15] and binds newly synthesized glycoproteins in living
cells possibly affecting the efficiency of oligosaccharides de-
glucosylation. However, our initial hypothesis that Malectin
participates in the Calnexin chaperone system was not confirmed
by experimental data. In fact, changes in the Malectin’s
intralumenal level did not affect the function of the ‘‘glucose-
based’’ Calnexin chaperone system (Figs. 2D, 2E–2G, Fig. S1).
This is testified by i) the equal amount of newly synthesized
cellular and viral glycoproteins associating with Calnexin, ii) the
unchanged kinetics of substrate release from Calnexin and iii) the
Malectin and Quality Control
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chaperone system) in cells with low, normal or elevated levels of
Malectin. In the case of HA, Calnexin and Malectin showed
clearly different kinetics of binding with a sharp peak in the early
phases after HA synthesis for Calnexin and a broader peak with a
maximal association about 20 min after synthesis for Malectin.
Calnexin and Malectin associated with distinct HA conformers. In
particular, Malectin showed persistent binding to extensively
oxidized ER-retained HA, which poorly associates with Calnexin.
It is possible that Malectin traps the minor fraction of HA that fails
to rapidly attain the native structure in the Calnexin chaperone
system. Certainly, it retains disulfide-bonded conformers expressed
under conditions that inhibit HA maturation.
Malectin interferes with oligosaccharide processing and
protein secretion
Analysis of the model cargo proteins a1AT and NHK, which
are characterized by slower, less efficient and less Calnexin-
dependent maturation compared to HA revealed that Malectin
overexpression may interfere with oligosaccharide processing and
secretion of select glycoproteins. The finding that the intervention
of the Golgi-resident endo-a-D-mannosidase was required for
conversion of NHK oligosaccharides to EndoH-resistant structures
is consistent with a model claiming that by binding glucosylated
structures as established in vitro [13,14,15], Malectin may interfere
with the activity of the ER-resident a-glucosidases thereby
reducing the efficiency of protein de-glucosylation. The Golgi
endo-mannosidase intervenes in fact under these circumstances to
remove terminal glucose residues and to allow complex glycosyl-
ation by Golgi-resident glycosyl transferases [31,32,33,36]. Appro-
priate sugar processing in the ER is a pre-requisite for efficient
cargo binding to cargo lectins that regulate ER export of a subset
of secretory proteins. It has been reported that the presence of
terminal glucose residues substantially inhibits cargo protein
association with cargo lectins [37]. It is therefore possible that
defective de-glucosylation and persistent Malectin association
contribute to a selective inhibition of the export of those
glycoproteins that rely on cargo lectins for secretion [38]. The
proposed interference of Malectin with the activity of ER-resident
a-glucosidases does not affect, as far as we can tell, the association
and the release of glycoproteins (of viral, ectopic or endogenous
origin (Figs. 2D–2G)) with Calnexin. One possibility is that
Calnexin and Malectin participate in two distinct chaperone
systems operating in parallel in the ER lumen. One could
speculate that upon overexpression, Malectin only determines the
fate of the fraction of a given polypeptide that enters the alternative
chaperone pathway. For HA, this fraction is very low because 3
oligosaccharides positioned at the polypeptide N-terminus elicit
co-translational entrance of nascent chains in the Calnexin
chaperone system [5,6,8] and exclude intervention of alternative
pathways [8]. For nascent glycoproteins with N-glycans late in the
sequence (e.g. the a1-antitrypsin variants analyzed here), parti-
tioning in alternative chaperone pathways is more likely to occur
[8]. For several ER-resident lectins such as Calnexin/Calreticulin
[39] and EDEM1 [40], the lectin function is dispensable for
association with misfolded conformers. It seems therefore relevant
to establish the role of the lectin site of Malectin for the in vivo
function of this novel ER-resident quality control factor. Since
Malectin is a stress-responsive gene, it is conceivable that
Malectin-regulated inhibition of cargo export is activated under
conditions of ER stress, possibly to avoid that defective gene
products are secreted under condition of aberrant functioning of
the ER quality control machineries.
Materials and Methods
Real Time PCR
For analysis of ER-stress induced gene transcription, cells were
plated in 6-cm dishes without (Mock) or with thapsigargin
300 nM. After 0-2-4-6-8 h cells were lysed in TRIzol reagent
(Invitrogen) and RNA isolated according to the instructions of the
manufacturer. Quantitative PCR was performed using 7900HT
Fast Real-Time PCR System. The PCR reaction mixtures were
performed in a 20 ml final volume, containing 10 ml Power SYBR
Green PCR master mix (Applied Biosystem), 5 ml cDNA, 4 ml
dH2O and 1 ml primer mix (0.5 mM final). The housekeeping gene
b-actin was used as reference. Data were analyzed using the SDS
2.2.2 software. The primers were as follows: b-actin, CTTCC-
TGGGCATGGAGTCCT (for) and GGAGCAATGATCTTGA-
TCTT (rev); BiP, GAGTTCTTCAATGGCAAGGA (for) and
CCAGTCAGATCAAATGTACCC (rev); EDEM1, AAGATTC-
CACCGTCCAAGTC (for) and GTATCATTGC TCCGGA-
GGTT (rev); Malectin, GACTATGGCATGAAACTGCC (for)
and GACTGTGCAAAGTAGACCTC (rev); Grp94, CTGGG-
ACTGGGAACTTATGAATG (for) and TCCATATTCGTCA-
AACAGACCAG (rev); spliced and unspliced XBP1, AAACA-
GAGTAGCAGCTCAGACTGC (for) and TCCTTCTGGGTA-
GACCTCTGGGA (rev).
Expression plasmids, antibodies and inhibitors
Plasmids and antibodies for the a1-antitrypsin variants are
described in [41,42]. A plasmid for expression of HA-tagged
Malectin was prepared by amplifying the protein coding sequence
from the full-length cDNA clone, product IRAUp969B111D
(Imagenes) with the primers CACCGAATTCCCACCATGCTG-
GGAGCCTGGGC and CCCACCCTCGAGTCA CAACCGG-
CAGAGGCAGAA. The construct was cloned upstream to a
sequence coding for a HA-tag in a pcDNA3 vector for expression
in mammalian cells. The monoclonal anti-HA and the polyclonal
anti-a1 antitrypsin were from Sigma, the polyclonals anti-
Calreticulin and anti-Calnexin (N-terminus) were from Stressgen.
The sequence of the HA-tag at the Malectin C-terminus
(YPYDVPDYA) is not present in the X-31 influenza virus HA.
Ectopically expressed Malectin was also immunoprecipitated with
a specific polyclonal antibody from Sigma.
Cell Lines, transient transfections
HEK293 and CHO cells (from ATTC) were grown in
appropriate culture media supplemented with 10% FBS. Cells at
80–90% confluence in a 6 cm tissue culture plate were transfected
with the expression plasmid of interest (4 mg for single transfec-
tions, 6 mg total DNA for double transfections) using Lipofecta-
mine 2000 (Invitrogen) according to the manufacturer instruc-
tions. Experiments were normally performed 17 hours after
transfection.
RNA interferences
For siRNA-based interference, HeLa cells (from ATTC) at 50%
confluence in a 3.5 tissue culture plate were transfected with
siRNA duplex (Ambion Inc, 50 pmol/dish) using Lipofectamine
2000 according to the manufacturer instructions. Four hours after
transfection, the medium was replaced with MEM Alpha supple-
mented with 1% of non-essential amino acids (GIBCO). Thirty
hours after siRNA transfection, cells were transfected with the
expression plasmids of interest. Experiments were performed
48 hours post-siRNA transfection. siRNA targeting sequences for
Malectin down-regulation: AGCUCACGAUGAAAUUAUA.
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and analysis of data
Eighteen hours after transfection (or four hours after infection
with the X-31 strain of influenza virus), cells were starved for
20 min in Met/Cys free medium, pulsed for 10 min with 50 mCi
[
35S]Met/Cys and chased for the indicated times with MEM
Alpha supplemented with 5 mM cold Met/Cys. Postnuclear
supernatant (PNS) was prepared by solubilization of cells in
400 ml/3,5 cm dish (or 800 ml/6 cm dish) ice-cold 2% CHAPS
(Anatrace) in HEPES-buffered saline (HBS), pH 6.8, contain-
ing 20 mM N-ethylmaleimide and protease inhibitors. CHAPS-
insoluble material was separated by centrifugation at 10’000 g for
10 min. Immunoprecipitations were performed by adding protein
A beads (Sigma; 1:10, w/v swollen in HBS) with the selected
antibody and incubated for 2 h at 4uC. Immunoprecipitates were
extensively washed (3610 min) with 0.5% CHAPS in HBS,
resuspended in sample buffer, boiled for 5 min and finally
separated in SDS-PAGE. Gels were exposed to BioMax (Kodak)
films and scanned with an Agfa scanner. Relevant bands were
quantified by ImageQuant software (Molecular Dynamics). Immu-
noblots were performed using the SNAP i.d. protein detection
system (Millipore). All primary antibodies were used at 1:200–
1:333 dilutions. Secondary antibodies were HRP-conjugated and
used at 1:10’000 dilutions. The ECL-Plus detection system was
from Amersham.
Subcellular Fractionation and Preparation of Membranes
Versus Luminal Content
Metabolically labeled cells were extensively washed in a 10-cm
dish with isotonic buffer. They were gently detached with a rubber
policeman and resuspended in 800 ml of homogenization buffer
(10 mm triethanolamine, 10 mm acetic acid, 250 mm sucrose,
20 mm N-ethylmaleimide, 1 mm EDTA, and a mixture of
protease inhibitors, pH 7.4). Cells were broken with 10–13
passages through a 22-gauge 1J needle. Postnuclear supernatants
were subjected to a first ultracentrifugation (100,000 6g in TLA
120.2) to separate endomembranes from the cytosol. The
endomembrane-containing pellet was washed twice and left for
25 min on ice in 500 ml of 100 mm Na2CO3 for carbonate
extraction of the luminal content. After an additional ultracentri-
fugation step (100,0006g in TLA 120.2), the luminal fraction was
harvested and supplemented with antibodies to Cnx, Crt, or to
HA-Malectin to determine their presence. The endomembrane
fraction was subjected to an additional washing step with 100 mm
Na2CO3 to minimize luminal contaminations and then resus-
pended in 800 ml of lysis buffer (2% CHAPS). The lysate was
subjected to ultracentrifugation to eliminate insoluble material and




5 cells expressing Malectin-HA were seeded in a 6 cm
Petri dishes containing 1% alcian blue treated glass cover slips.
Cover slips were rinsed with PBS, and cells were fixed in 3,7%
formaldehyde. After 2 short washings with 10 mM Hepes serum-
free medium, and two additional washing with PBS, the antigen
accessibility was improved by a 20-min incubation with 0,05%
saponin, 10% Goat serum, 10 mM Hepes, 15 mM glycine. The
monoclonal anti-HA (Sigma), the polyclonal anti-Calnexin), the
Alexa 488-labeled goat anti-rabbit and the Alexa 594-labeled goat
anti-mouse antibodies were diluted (1:100) in the latter solution.
Images were viewed on a Nikon eclipse E-800 fluorescent
microscope, captured by a Hamamatsu EM-CCD Digital camera
C9100 and analysed with the Open lab 3 software (Improvision,
Inc., Lexington, MA).
Supporting Information
Figure S1 Malectin down-regulation does not affect HA
maturation or NHK secretion. A Malectin down-regulation
by specific RNA interference. B Influenza virus HA was
immunoisolated from detergent lysates of influenza virus-infected
cells with normal (lanes 1–3) or reduced levels of Malectin (RNAi,
lanes 4–6). C Release of Influenza virus HA from Calnexin in cells
with normal (lanes 1–3) or reduced levels of Malectin (RNAi, lanes
4–6) analyzed in a reducing gel. D Assessment of EndoH-
sensitivity of oligosaccharides displayed on HA expressed in cells
with normal (lanes 1–6) or reduced (lanes 7–12) levels of Malectin.
Res, EndoH-resistant HA; Sens, EndoH-sensitive HA. E Efficien-
cy of Malectin down-regulation upon specific RNAi. F Disap-
pearance of labeled NHK from control HEK293 cells (lanes 1–3)
and from HEK293 cells expressing reduced levels of Malectin
(lanes 4–6). G NHK secretion from control cells (lanes 1–3) and
from cells expressing reduced levels of Malectin (lanes 4–6).
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